@misc{indiciaef6f0ded7b8dd,
  title = {Epigenetic inhibitors sensitize DLBCL cells to rituximab and doxorubicin},
  author = {Facciotto, C. and Casado, J. and Turunen, L. and Leivonen, S.-K. and Tumiati, M. and Rantanen, V. and Kauppi, L. and Lehtonen, R. and Leppä, S. and Wennerberg, K. and Hautaniemi, S.},
  year = {2019},
  doi = {10.1101/538199},
  url = {https://www.biorxiv.org/content/10.1101/538199v1},
  note = {Source identifier: 10.1101/538199}
}